NCT01461356

Brief Summary

The hypothesis of the proposed study is that performing total knee arthroplasty through a mini subvastus approach results in statistically significant differences in one or more of the above functional outcome measures, when compared in a blinded, prospective, controlled, randomized manner to mini-medial arthrotomy approach.

  1. 1.Analyses of lower extremity functional activities (gait and stairs)
  2. 2.Strength of thigh musculature
  3. 3.Self-assessment of the functional outcomes
  4. 4.Return to the activities of daily living and sports activities

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable knee-osteoarthritis

Timeline
Completed

Started Mar 2007

Longer than P75 for not_applicable knee-osteoarthritis

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2007

Completed
4.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2011

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

October 20, 2011

Completed
8 days until next milestone

First Posted

Study publicly available on registry

October 28, 2011

Completed
Last Updated

October 28, 2011

Status Verified

October 1, 2011

Enrollment Period

4.5 years

First QC Date

October 20, 2011

Last Update Submit

October 27, 2011

Conditions

Outcome Measures

Primary Outcomes (1)

  • Knee Society Clinical Rating Score

    The two patient cohorts, minimally invasive surgical approach and standard medial parapatellar approach, will be followed prospectively and evaluated with the Knee Society Clinical Rating Score.

    2 months

Secondary Outcomes (1)

  • Comprehensive gait analysis

    2 months

Study Arms (2)

Minimally Invasive Surgical approach

EXPERIMENTAL

Minimally invasive surgical approach for total knee replacement.

Procedure: Minimally invasive total knee replacement

Medial Parapatellar surgical approach

ACTIVE COMPARATOR

Standard medial parapateller surgical approach for total knee replacement.

Procedure: Standard approach total knee replacement

Interventions

A cemented tricompartmental total knee replacement will be performed using a minimally invasive surgical approach.

Also known as: Posterior stabilzed total knee replacement., Minimally invasive total knee replacement.
Minimally Invasive Surgical approach

A cemented tricompartmental total knee replacement will be performed using a traditional medial parapatellar surgical approach.

Also known as: Posterior stabilized total knee replacement., Minimally invasive total knee replacment.
Medial Parapatellar surgical approach

Eligibility Criteria

Age45 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Primary arthroplasty
  • Age between 45 and 75 years old
  • Single condylar implant design

You may not qualify if:

  • Revision arthroplasty
  • Age less than 45 and greater than 75 years old
  • Pre-operative flexion lower than 90 degrees
  • Valgus or varus knee deformity greater than 15 degrees.
  • The presence of infections, highly communicable diseases (AIDS, active tuberculosis, venereal disease, hepatitis) or metastasis disease.
  • Significant neurological or musculoskeletal disorders or disease that may interfere with normal gait or weight bearing.
  • Any congenital, developmental, or other bone disease or previous hip surgery that may, in the surgeon's judgment, interfere with TK prosthesis survival or success.
  • Presence of previous prosthetic knee or hip replacement device.
  • BMI \> 30.
  • Pregnant women.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mayo Clinic

Rochester, Minnesota, 55905, United States

Location

MeSH Terms

Conditions

Osteoarthritis, Knee

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Study Officials

  • Mark W Pagnano, MD

    Mayo Clinic

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

October 20, 2011

First Posted

October 28, 2011

Study Start

March 1, 2007

Primary Completion

September 1, 2011

Study Completion

September 1, 2011

Last Updated

October 28, 2011

Record last verified: 2011-10

Locations